Previous close | 535.77 |
Open | 538.23 |
Bid | 386.64 x 200 |
Ask | 690.98 x 200 |
Day's range | 537.71 - 543.20 |
52-week range | 327.73 - 554.74 |
Volume | |
Avg. volume | 364,132 |
Market cap | 32.171B |
Beta (5Y monthly) | 0.31 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.50 |
Earnings date | 31 Oct 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 541.48 |
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. The equity markets performed well in the second quarter, as long as one held only a small number of the biggest, fastest-growing U.S. stocks. Given the Magnificent Seven’s […]
Biotech stocks have been rallying as funds load up. Five stocks have been outperforming the vast majority in the IBD database.
Argenx (ARGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.